Mediators of Inflammation
Volume 2020 (2020), Article ID 2637019, 1 page
https://doi.org/10.1155/2020/2637019

Corrigendum

Corrigendum to “I-alowCD11bhigh DC Regulates the Immune Response in the Eyes of Experimental Autoimmune Uveitis”

Yu Zhao,¹ Jingwen Wang,² Zhang Min,³ Li Peng,¹ Shuhong Qi,4,5 and Wei Lin¹

¹Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Schools, Jinan City 250062, China
²The Third Affiliated Hospital of Shandong First Medical University, Affiliated Hospital of Shandong Academy of Medical Schools, 38# Wuyingshan Road, Jinan City 250031, China
³Departments of Medicine, Tibet Nationalities University, Xian City 712082, China
⁴Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology, Wuhan, Hubei 430074, China
⁵MoE Key Laboratory for Biomedical Photonics, Collaborative Innovation Center for Biomedical Engineering, School of Engineering Sciences, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China

Correspondence should be addressed to Wei Lin; linw1978@163.com

Received 26 October 2020; Accepted 26 October 2020; Published 28 November 2020

Copyright © 2020 Yu Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “I-alowCD11bhigh DC regulates the immune response in the eyes of experimental autoimmune uveitis” [1], affiliation 1 was incorrect and the correct affiliation is shown above. The authors also requested to correct a typographical error in the Methods and Materials section as follows:

“EAU in C57BL/6 mice was inducted by the 350 μg of human interphotoreceptor retinoid-binding protein peptide (IRBP)1-20 (China Peptides Co.,Ltd., Shanghai, China) emulsified in complete Freund’s adjuvant with mycobacterium (CFA, Sigma-Aldrich, St. Louis, MO, USA). A total of 500 ng of Pertussis toxin (PTX, Enzo Life Sciences, Farmingdale, YN, USA) was intraperitoneally injected at the footpad, neck, two sides, and tail at six points for every mouse as previously described [35]”

should be corrected as follows:

“EAU in C57BL/6 mice was inducted by the 350 μg of human interphotoreceptor retinoid-binding protein peptide (IRBP)₁₋₂₀ (China Peptides Co., Ltd., Shanghai, China) emulsified in complete Freund’s adjuvant with mycobacterium (CFA, Sigma-Aldrich, St. Louis, MO, USA) and was immunized at six different locations (footpads, neck, two sides, and tail). Concurrently, a total of 500 ng of pertussis toxin (PTX, Enzo Life Sciences, Farmingdale, NY, USA) was injected intraperitoneally for every mouse as previously described [35].”

References

Y. Zhao, J. Wang, Z. Min, L. Peng, S. Qi, and W. Lin, “I-alowCD11bhigh DC Regulates the Immune Response in the Eyes of Experimental Autoimmune Uveitis,” Mediators of Inflammation, vol. 2020, Article ID 6947482, 15 pages, 2020.